Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

After Statins, What Next?

Apr 01 2008

• By Melanie Senior

Related Content

The Unsung Vytorin Victim: Primary-Care Marketing

Feb 01 2008

Genzyme/Isis: Has ENHANCE Dulled Mipomersen's Prospects?

Feb 01 2008

Merck's Cordaptive: Just Another Cholesterol Combo, or More?

Apr 01 2008

Metabolex and J&J: Why Biotech's Pipelines Needs Pharma's

Jul 01 2006

Related Companies

Pfizer Inc.

AtheroGenics, Inc.

Schering-Plough

Merck & Co., Inc.

QuatRx Pharmaceuticals Co

Karo Pharma AB

Resverlogix Corporation

Exelixis, Inc.

Abionyx Pharma

VIA Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

Sanofi Genzyme

GSK plc

Roche Holding AG

Japan Tobacco Inc.

Bird Rock Bio, Inc.

Arisaph Pharmaceuticals, Inc.

SemBioSys Genetics Inc.

Bristol Myers Squibb Company

Takeda Pharmaceutical Co. Ltd.

Alnylam Pharmaceuticals Inc.

The University of Texas System

Roche Holding AG

Metabasis Therapeutics

Abbott

CymaBay Therapeutics, Inc.

Johnson & Johnson

Genfit SA

Stanford University

Anthera Pharmaceuticals, Inc.

Eli Lilly and Company

AstraZeneca PLC

BioInvent International AB

Genentech, Inc.

Takeda Pharmaceutical Co. Ltd.

Bayer AG

Additional Topics

Business Strategies Clinical Trials Platform Technologies Regulation BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window